Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 20;27(1):98.
doi: 10.1007/s11886-025-02250-7.

The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care

Jina Chung  1   2 , Jenica Thangathurai  3 , Sharon Andrade-Bucknor  4 , Susmita Parashar  5 , Karina Gonzalez Carta  6 , Marc Epp  7 , Carol Ma  8
Affiliations
Review

The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care

Jina Chung et al. Curr Cardiol Rep. .

Abstract

Purpose of review: To review current artificial intelligence (AI) applications impacting cardiovascular disease care in women.

Recent findings: Women differ from men in cardiovascular anatomy, physiology, presentation, and treatment response, yet face disparities due to underrepresentation in trials and referral bias. AI applications offer promising tools to close these gaps by enhancing screening, diagnosis, monitoring, and treatment. This review explores female representation, outcomes, and future directions in AI-driven advancements in coronary artery disease, heart failure with preserved ejection fraction, valvular heart disease, ischemic and nonischemic cardiomyopathies, including peripartum cardiovascular disease. AI holds the potential to transform cardiovascular disease care in women by leveraging multidimensional datasets for sex-specific screening, risk prediction, prognostic phenomapping and therapeutic decision support. Expanding female representation and integrating sex-specific factors in AI research are essential to minimize bias, ensure robust external validation and enable equitable, scalable implementation.

Keywords: Artificial Intelligence; Deep Learning; Health Equity; Machine Learning; Sex-specific Differences; Women’s Cardiovascular Disease.

PubMed Disclaimer

Conflict of interest statement

Declarations. Human and Animal Rights and Informed Consent: No animal or human subjects by the authors were used in this study. Competing Interests: The authors declare no competing interests.

References

    1. Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–438. https://doi.org/10.1016/S0140-6736(21)00684-X . - DOI - PubMed
    1. Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141(7):540–8. https://doi.org/10.1161/CIRCULATIONAHA.119.043594 . - DOI - PubMed
    1. Vervoort D, Wang R, Li G, Filbey L, Maduka O, Brewer LC, et al. Addressing the global burden of cardiovascular disease in women: JACC State-of-the-Art review. J Am Coll Cardiol. 2024;83(25):2690–707. https://doi.org/10.1016/j.jacc.2024.04.028 . - DOI - PubMed
    1. Sarraju A, Ouyang D. Navigating the Gray Zone: AI Decision Support to Identify Aortic Stenosis Severity. JACC Adv. vol 9. United States2024. p. 101178.
    1. Mihan A, Pandey A, Van Spall HG. Mitigating the risk of artificial intelligence bias in cardiovascular care. Lancet Digit Health. 2024;6(10):e749–54. https://doi.org/10.1016/S2589-7500(24)00155-9 . - DOI - PubMed

LinkOut - more resources